FREE Case Review (866) 588-0600

Xarelto Leads Pradaxa in Sales, Side Effects: Report

A new report suggests that Xarelto has recently gained market share over its major competitor Pradaxa.

A new report suggests that Xarelto (rivaroxaban), a blood-thinning drug, has recently gained market share over its major competitor Pradaxa (dabigatran). However, with its increased popularity also comes an increase in complaints about Xarelto from patients who have allegedly suffered uncontrollable internal bleeding events after taking the drug. These complaints may lead to the filing of additional Xarelto Lawsuits.

Free Confidential Lawsuit Evaluation: If you or a loved one has been injured by Pradaxa, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.

What’s the Problem?

Both Xarelto and Pradaxa are anticoagulant drugs that decrease the body’s ability to form blood clots. While clotting is important for the body’s healing process, this mechanism can sometimes misfire and actually cause blood clots to form in a person’s body. When this occurs, the clot can become trapped in blood vessels, blocking blood supply to the brain, heart or lungs, causing a stroke, heart attack, or pulmonary embolism (PE). Anticoagulants like Xarelto and Pradaxa can help reduce this risk. Unfortunately, these drugs also carry a number of potential health risks.

Anytime a person uses an anticoagulant drug, there’s a risk of internal bleeding. When this happens, the person can face a life-threatening medical emergency from a minor injury. This may include internal complications, which can be difficult to diagnose until it’s too late. Older blood-thinning drugs have antidotes and reversal agents. With warfarin, for example, a single dose of vitamin K can deactivate it and allow the patient to clot again. However, it has been alleged that as drug patents expire, manufacturers of these products are motivated to develop new blood-thinners with new patents and promote them over the older products. However, there is no known antidote for Xarelto and Pradaxa, making it much more difficult to manage uncontrollable bleeding events.

A May 2014 study by the Institute for Safe Medication Practices (ISMP) contained a section entitled “Anticoagulant Update.” The report classified all blood-thinners as high-risk treatments, with as many as 15%  of users reporting unanticipated bleeds. The study also found that there was a massive increase in prescriptions for the newer anticoagulants, with Xarelto becoming more common, and prescriptions for Pradaxa dropping after peaking in 2012. ISMP recommends a two-pronged strategy for reducing the occurrence of internal bleeding events. First, the institute recommends lowering the dosage. Next, it recommends routine lab testing to monitor patients’ reactions to the drugs.

Do I Have a Pradaxa Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Pradaxa lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.

Free Confidential Case Evaluation: Again, if you or a loved one was injured by Pradaxa, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition